who should not take glp-1 drugs nausea: How to handle GLP-1s' most common side effect Wait - Maybe You Should
Description
The trial, called SELECT, was conducted in 41 countries with more than 17,000 people who were overweight or obese and at high cardiovascular risk but who didnt have diabetes
Heterogeneity among studies was assessed using the I 2 statistic, with an I 2 value of 50 % or higher indicating obvious heterogeneity
They are significantly more difficult to administer than pills, and many patients fear needles
Hubert P.E
2025;45:e70256
The physiological changes that accompany GLP-1 therapy can create conditions where tiredness becomes more noticeable
